Study the Efficacy and Safety of PTK 0796 in Patients With Complicated Skin and Skin Structure Infection (CSSSI)

Clinical trial NCT03716024 · COMPLETED

Trial details

NCT number: NCT03716024
Sponsor: Paratek Pharmaceuticals Inc
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Infectious Skin Disease Bacterial Skin Disease

Start date: 2007-07-18
Primary completion: 2008-01-07
Enrollment: 234

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.